Product Information

LEVETIRACETAM ER 750 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2367 per EA under NDC 68180011807. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Sep 12, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM ER 750 MG TABLET

Levetiracetam
$0.2367per EA

Strength

750 mg/1

NDC

68180011807

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA091399

FDA Approved

9/12/2011

TE Code

AB

On Market Since

9/12/2011

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM ER 750 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 61.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2367 per EA
All-time high$0.7355 (Jun 10, 2015)
All-time low$0.1819 (Nov 20, 2024)
52-week high$0.2613
52-week low$0.2104
Median price$0.5006
Average price$0.4525
Largest weekly change+50.1% (Aug 21, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+5.9%

3M

+6.8%

6M

-2.7%

1Y

-10.9%

3Y

+1.2%

5Y

-54.4%

All

-61.2%

Generic Alternatives

The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 55% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM ER 750 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM ER 750 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.2367 per EA (NDC 68180011807), effective Nov 11, 2026.

How has the price of LEVETIRACETAM ER 750 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM ER 750 MG TABLET has declined 61.2%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM ER 750 MG TABLET?

Since Nov 28, 2013, the NADAC for LEVETIRACETAM ER 750 MG TABLET has ranged from a low of $0.1819 (Nov 20, 2024) to a high of $0.7355 (Jun 10, 2015), with a median of $0.5006 per EA.

Are there cheaper alternatives to LEVETIRACETAM ER 750 MG TABLET?

Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1056 per EA — about 55% below LEVETIRACETAM ER 750 MG TABLET.

Who manufactures LEVETIRACETAM ER 750 MG TABLET?

LEVETIRACETAM ER 750 MG TABLET (NDC 68180011807) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.